BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 38605399)

  • 1. The implications of single-cell RNA-seq analysis in prostate cancer: unraveling tumor heterogeneity, therapeutic implications and pathways towards personalized therapy.
    Feng DC; Zhu WZ; Wang J; Li DX; Shi X; Xiong Q; You J; Han P; Qiu S; Wei Q; Yang L
    Mil Med Res; 2024 Apr; 11(1):21. PubMed ID: 38605399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell RNA sequencing in breast cancer: Understanding tumor heterogeneity and paving roads to individualized therapy.
    Ding S; Chen X; Shen K
    Cancer Commun (Lond); 2020 Aug; 40(8):329-344. PubMed ID: 32654419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-cell omics traces the heterogeneity of prostate cancer cells and the tumor microenvironment.
    Yu X; Liu R; Gao W; Wang X; Zhang Y
    Cell Mol Biol Lett; 2023 May; 28(1):38. PubMed ID: 37161356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metronomic Administration of Topotecan Alone and in Combination with Docetaxel Inhibits Epithelial-mesenchymal Transition in Aggressive Variant Prostate Cancers.
    Mitra Ghosh T; Mazumder S; Davis J; Yadav J; Akinpelu A; Alnaim A; Kumar H; Waliagha R; Church Bird AE; Rais-Bahrami S; Bird RC; Mistriotis P; Mishra A; Yates CC; Mitra AK; Arnold RD
    Cancer Res Commun; 2023 Jul; 3(7):1286-1311. PubMed ID: 37476073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering cell-cell interactions and communication in the tumor microenvironment and unraveling intratumoral genetic heterogeneity via single-cell genomic sequencing.
    Cao YH; Ding J; Tang QH; Zhang J; Huang ZY; Tang XM; Liu JB; Ma YS; Fu D
    Bioengineered; 2022; 13(7-12):14974-14986. PubMed ID: 37105769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Innovative prognostic modeling in ESCC: leveraging scRNA-seq and bulk-RNA for dendritic cell heterogeneity analysis.
    Shi M; Zhang H; Ma L; Wang X; Sun D; Feng Z
    Front Immunol; 2024; 15():1352454. PubMed ID: 38515748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell RNA combined with bulk RNA analysis to explore oxidative stress and energy metabolism factors and found a new prostate cancer oncogene
    Miao M; Song Y; Jin M; Du Y; Xin P; Jiang Y; Zhang H
    Aging (Albany NY); 2024 Mar; 16(5):4469-4502. PubMed ID: 38441550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New insights from the single-cell level: Tumor associated macrophages heterogeneity and personalized therapy.
    Wang X; Xu Y; Sun Q; Zhou X; Ma W; Wu J; Zhuang J; Sun C
    Biomed Pharmacother; 2022 Sep; 153():113343. PubMed ID: 35785706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Revolutionizing cancer immunotherapy in solid tumor: CAR engineering and single-cell sequencing insights.
    Pu Z; Wang TB; Mou L
    Front Immunol; 2023; 14():1310285. PubMed ID: 38090577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The molecular landscape of neurological disorders: insights from single-cell RNA sequencing in neurology and neurosurgery.
    Awuah WA; Ahluwalia A; Ghosh S; Roy S; Tan JK; Adebusoye FT; Ferreira T; Bharadwaj HR; Shet V; Kundu M; Yee ALW; Abdul-Rahman T; Atallah O
    Eur J Med Res; 2023 Nov; 28(1):529. PubMed ID: 37974227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the current landscape of single-cell RNA sequencing applications in gastric cancer research.
    Awuah WA; Roy S; Tan JK; Adebusoye FT; Qiang Z; Ferreira T; Ahluwalia A; Shet V; Yee ALW; Abdul-Rahman T; Papadakis M
    J Cell Mol Med; 2024 Apr; 28(7):e18159. PubMed ID: 38494861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Review of Single-Cell RNA-Seq Annotation, Integration, and Cell-Cell Communication.
    Cheng C; Chen W; Jin H; Chen X
    Cells; 2023 Jul; 12(15):. PubMed ID: 37566049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration analysis of single-cell and spatial transcriptomics reveal the cellular heterogeneity landscape in glioblastoma and establish a polygenic risk model.
    Liu Y; Wu Z; Feng Y; Gao J; Wang B; Lian C; Diao B
    Front Oncol; 2023; 13():1109037. PubMed ID: 37397378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deciphering colorectal cancer immune microenvironment transcriptional landscape on single cell resolution - A role for immunotherapy.
    Tieng FYF; Lee LH; Ab Mutalib NS
    Front Immunol; 2022; 13():959705. PubMed ID: 36032085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-Cell RNA Sequencing: Technological Progress and Biomedical Application in Cancer Research.
    Chang X; Zheng Y; Xu K
    Mol Biotechnol; 2023 Jun; ():. PubMed ID: 37322261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer.
    Heidegger I; Fotakis G; Offermann A; Goveia J; Daum S; Salcher S; Noureen A; Timmer-Bosscha H; Schäfer G; Walenkamp A; Perner S; Beatovic A; Moisse M; Plattner C; Krogsdam A; Haybaeck J; Sopper S; Thaler S; Keller MA; Klocker H; Trajanoski Z; Wolf D; Pircher A
    Mol Cancer; 2022 Jun; 21(1):132. PubMed ID: 35717322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining single-cell sequencing and spatial transcriptome sequencing to identify exosome-related features of glioblastoma and constructing a prognostic model to identify BARD1 as a potential therapeutic target for GBM patients.
    Zhao S; Wang Q; Ni K; Zhang P; Liu Y; Xie J; Ji W; Cheng C; Zhou Q
    Front Immunol; 2023; 14():1263329. PubMed ID: 37727789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-cell RNA sequencing in human lung cancer: Applications, challenges, and pathway towards personalized therapy.
    Chong ZX; Ho WY; Yeap SK; Wang ML; Chien Y; Verusingam ND; Ong HK
    J Chin Med Assoc; 2021 Jun; 84(6):563-576. PubMed ID: 33883467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promising immunotherapeutic targets in lung cancer based on single-cell RNA sequencing.
    Xue Q; Peng W; Zhang S; Wei X; Ye L; Wang Z; Xiang X; Zhang P; Zhou Q
    Front Immunol; 2023; 14():1148061. PubMed ID: 37187731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future directions for precision oncology in prostate cancer.
    Mizuno K; Beltran H
    Prostate; 2022 Aug; 82 Suppl 1(Suppl 1):S86-S96. PubMed ID: 35657153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.